
Adenoid Cystic Carcinoma (ACC) is a rare cancer found in most cases within the salivary glands. However, it is also able to be found elsewhere in the body including the female breast/right atrium/breast/mammary gland, respiratory transitions, vagina, and female anatomy. ‘Adenoid cystic carcinoma is a slowly growing cancer that tends to spread along nerves aggressively.
Causes
Risk Factors:
The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.
The medical treatment for Adenoid Cystic Carcinoma requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgical Management: Surgery is usually the primary modality in treating Adenoid Cystic Carcinoma (ACC). The goal is to completely resect the tumour with clear margins. For tumors in the head and neck or salivary glands, wide local excision is standard.
Radiation therapy: When surgery cannot altogether remove the tumor or if there is a high risk for recurrence, most likely, it will be radiation therapy afterward. These are advanced radiation techniques; two examples are IMRT and proton therapy. This has the least effect on the surroundings.
Chemotherapy : ACCs usually respond poorly to standard chemotherapy drugs, so their use is discouraged in such cases. In exceptional cases with metastatic or advanced disease, or when surgery and radiotherapy are not good options or not possible in that situation, chemotherapy might be attempted.
Cost Start From USD 600 - USD 700Explore Options
Targeted Therapy: It is an emerging therapy that targets the selected molecular mutations in ACC. Tyrosine kinase inhibitors are in the pretesting stages, but they are helpful research questions in the treatment possibilities of advanced cases.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : ACC immunological research concerns the immune checkpoint blockade, especially in the more advanced stages. For advanced and relapsing cases, palliative care focuses more on symptom management and quality of life improvement.
Cost Start From USD 3000 - USD 5000Explore Options
These are the standard diagnostic methods for diagnosing Adenoid Cystic Carcinoma:
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support patients in India. Additional services are as per the patient's requirement. These services include:
Treatment options for Adenoid Cystic Carcinoma (ACC) may often include chemotherapy. Still, it has been known to be less successful. However, there are emerging and targeted forms of therapy through tyrosine kinase inhibitors versus other phenomena that involve immunotherapy via immune checkpoint inhibitors for advanced stages.









Bangalore, India
Apollo Hospitals Bannerghatta located in Bengaluru, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Bangalore, India
HCG Kalinga Rao Road located in Bengaluru, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:

Faridabad, India
Sarvodaya Hospital and Research Centre located in Faridabad, India is accredited by NABH, NABL. Also listed below are some of the most prominent infrastructural details:
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
The following are the much-growing reasons for India being frequented for Adenoid Cystic Carcinoma treatment:
ACC is a treatable but not easily curable cancer. If diagnosed early and treated appropriately, there is a good chance of managing the disease, but recurrence is common due to its slow-growing nature. Long-term follow-up is essential.
The prognosis for ACC depends on the tumour’s location, stage, and whether it has spread. With early detection and treatment, the survival rate is relatively good, but the disease’s tendency to recur or spread makes regular monitoring important.
While slow-growing, ACC can spread to other areas, particularly the lungs, bones, and liver. If the cancer metastasises, it becomes harder to treat but not impossible.
There are no known methods to prevent ACC. However, reducing exposure to radiation and avoiding smoking may lower the risk of developing certain cancers, including ACC.
ACC is a rare cancer in India, though it occurs in both adults and children, primarily affecting the salivary glands, head, neck, and airway. It is less common compared to other cancers but can still be diagnosed with increasing awareness.
The survival rate for ACC in India depends on early detection and treatment. With timely surgery and radiation therapy, many patients achieve favorable outcomes, though the disease tends to recur over time, requiring long-term monitoring.

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.
During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.
Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.
In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.
Her research work is accessible through the following links:
https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en
https://carcinogenesis.com/index.php/JOC/article/view/870
https://carcinogenesis.com/index.php/JOC/article/view/868
https://wjpsronline.com/abstract/0000000760
View More
Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026